Douglas G. Johns

4.3k total citations
77 papers, 2.6k citations indexed

About

Douglas G. Johns is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Douglas G. Johns has authored 77 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 32 papers in Surgery and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Douglas G. Johns's work include Lipoproteins and Cardiovascular Health (17 papers), Cholesterol and Lipid Metabolism (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Douglas G. Johns is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Cholesterol and Lipid Metabolism (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Douglas G. Johns collaborates with scholars based in United States, United Kingdom and Netherlands. Douglas G. Johns's co-authors include Stephen A. Douglas, R. Clinton Webb, Shanqin Xu, Richard A. Cohen, Hui Di Wang, Zhaohui Ao, R. Clinton Webb, Antonio J. Cayatte, Mark T. Quinn and Yue Du and has published in prestigious journals such as Circulation Research, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Douglas G. Johns

77 papers receiving 2.6k citations

Peers

Douglas G. Johns

SURGE

CCM

EDM

PHYSI

Debra L. Rateri United States

Harrihar A. Pershadsingh United States

Saša Frank Austria

Mitsuyo Okazaki Japan

David A. Beebe United States

B H Chung United States

David G. Hassall United Kingdom

Gert M. Kostner Austria

Baohai Shao United States

Akira Uruno Japan

Debra L. Rateri United States

Douglas G. Johns

1.0k ×1.1

1.3k ×1.6

SURGE

1.3k ×1.9

CCM

659 ×1.2

EDM

609 ×1.1

PHYSI

Citations per year, relative to Douglas G. Johns Douglas G. Johns (= 1×) peers Debra L. Rateri

Countries citing papers authored by Douglas G. Johns

Since Specialization

Citations

This map shows the geographic impact of Douglas G. Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas G. Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas G. Johns more than expected).

Fields of papers citing papers by Douglas G. Johns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas G. Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas G. Johns. The network helps show where Douglas G. Johns may publish in the future.

Co-authorship network of co-authors of Douglas G. Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas G. Johns. A scholar is included among the top collaborators of Douglas G. Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas G. Johns. Douglas G. Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Ben J., Yue Li, Kwok Leung Ong, et al.. (2019). The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits. Scientific Reports. 9(1). 16183–16183. 1 indexed citations

Johns, Douglas G., Mihajlo L. Krsmanovic, Min Lu, et al.. (2018). Characterization of Anacetrapib Distribution into the Lipid Droplet of Adipose Tissue in Mice and Human Cultured Adipocytes. Drug Metabolism and Disposition. 47(3). 227–233. 5 indexed citations

McLaren, David G., Stephen F. Previs, Robert D. Phair, et al.. (2016). Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux. Journal of Lipid Research. 57(3). 398–409. 9 indexed citations

Hartmann, Gunther, Sanjeev Kumar, Douglas G. Johns, et al.. (2015). Disposition into Adipose Tissue Determines Accumulation and Elimination Kinetics of the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Mice. Drug Metabolism and Disposition. 44(3). 428–434. 13 indexed citations

Zhang, Meng, Huimin Tong, Lei Zhang, et al.. (2015). HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation. Scientific Reports. 5(1). 8741–8741. 49 indexed citations

Wang, Shengping, Ying Chen, José Castro‐Perez, et al.. (2013). In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption. Journal of Lipid Research. 54(10). 2858–2865. 13 indexed citations

McLaren, David G., Steven J. Stout, Dan Xie, et al.. (2012). Tracking fatty acid kinetics in distinct lipoprotein fractions in vivo: a novel high-throughput approach for studying dyslipidemia in rodent models. Journal of Lipid Research. 54(1). 276–281. 12 indexed citations

Johns, Douglas G., Joseph Duffy, Timothy S. Fisher, Brian K. Hubbard, & Michael J. Forrest. (2012). On- and Off-Target Pharmacology of Torcetrapib. Drugs. 72(4). 491–507. 39 indexed citations

Gutstein, David E., Rajesh Krishna, Douglas G. Johns, et al.. (2011). Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction. Clinical Pharmacology & Therapeutics. 91(1). 109–122. 47 indexed citations

10.

Han, Seongah, Amy Flattery, David G. McLaren, et al.. (2011). Comparison of Lipoprotein Separation and Lipid Analysis Methodologies for Human and Cynomolgus Monkey Plasma Samples. Journal of Cardiovascular Translational Research. 5(1). 75–83. 11 indexed citations

11.

Previs, Stephen F., Ablatt Mahsut, Christopher Johnson, et al.. (2011). Quantifying cholesterol synthesis in vivo using 2H2O: enabling back-to-back studies in the same subject. Journal of Lipid Research. 52(7). 1420–1428. 17 indexed citations

12.

Johns, Douglas G., Zhaohui Ao, Nabil A. Elshourbagy, et al.. (2007). Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor. Biochemical and Biophysical Research Communications. 358(1). 145–149. 35 indexed citations

13.

Bao, Weike, David J. Behm, Sandhya S. Nerurkar, et al.. (2007). Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production. Journal of Cardiovascular Pharmacology. 49(6). 362–368. 89 indexed citations

14.

Song, Wei, Weiqun Lu, Ao Zhang, et al.. (2006). Urotensin II and renal function in the rat. Kidney International. 69(8). 1360–1368. 56 indexed citations

15.

Johns, Douglas G., Zhaohui Ao, Marianne Eybye, et al.. (2005). Rosiglitazone Protects against Ischemia/Reperfusion-Induced Leukocyte Adhesion in the Zucker Diabetic Fatty Rat. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1020–1027. 19 indexed citations

16.

Douglas, Stephen A., Eliot H. Ohlstein, & Douglas G. Johns. (2004). Techniques: Cardiovascular pharmacology and drug discovery in the 21st century. Trends in Pharmacological Sciences. 25(4). 225–233. 5 indexed citations

17.

Atkins, Kevin B., Douglas G. Johns, Stephanie W. Watts, R. Clinton Webb, & Frank C. Brosius. (2001). Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. Journal of Hypertension. 19(9). 1581–1587. 27 indexed citations

18.

Johns, Douglas G., et al.. (2000). Novel signaling pathways contributing to vascular changes in hypertension. Journal of Biomedical Science. 7(6). 431–443. 27 indexed citations

19.

Johns, Douglas G., Jong-Shiaw Jin, Dixon W. Wilde, & R. Clinton Webb. (1999). Ceramide-induced vasorelaxation An inhibitory action on protein kinase C. General Pharmacology The Vascular System. 33(5). 415–421. 15 indexed citations

20.

Johns, Douglas G., Jong-Shiaw Jin, & R. Clinton Webb. (1998). The role of the endothelium in ceramide-induced vasodilation. European Journal of Pharmacology. 349(2-3). R9–R10. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact